Background: Latent Tuberculosis treatment is a key tuberculosis control intervention. Adolescents are a high risk group that is not routinely treated in low income countries. Knowledge of latent Tuberculosis (TB) burden among adolescents may influence policy. Objectives: We determined the prevalence and risk factors of latent TB infection among adolescents in rural Uganda. Methods: We analyzed baseline data from a study that assessed the prevalence and incidence of Tuberculosis disease among adolescents. We extracted socio-demographics, medical assessment information, and tuberculin skin test results and estimated prevalence ratios (PR) of latent TB infection risk factors by binomial regression. Results: The prevalence of latent TB was 16.1%, 95% CI (15.1 -17.2). Significant risk factors were: a BCG scar, APR 1.29 (95% CI 1.12 -1.48); male gender, APR 1.37 (95% CI 1.21 -1.56); age 17 -18 years, APR 1.46 (95% CI 1.24 -1.71) and 15-16 years, APR 1.25 (95% CI 1.07 -1.46) compared to 12-14 years; being out of school, APR 1.31 (95% CI 1.05 -1.62); and a known history of household TB contact in last 2 years, APR 1.91 (95% CI 1.55 -2.35) Conclusion: Targeted routine latent TB treatment among adolescents out of school may be crucial for TB disease control in low income countries.
Introduction
Tuberculosis (TB) is one of the commonest infectious diseases in the world. In 2012 the estimated global burden of disease was 8.6 million cases 1 . Considerable TB control success has been registered through interruption of disease transmission. This has been achieved by identifying and treating persons with the disease 2, 3 . Following infection with TB, an individual's immunity can suppress TB organisms to a Latent TB infection (LTBI) state. Reactivation may occur many years after infection leading to active disease and has been documented as an important source of new active disease 4 . Whereas high income countries have incorporated the diagnosis and treatment of latent TB infection among all individuals in their TB control programs, low income countries usually target this intervention for only HIV infected patients and children with a household TB contact 5 , the groups at highest risk of LTBI reactivation.
There is a sudden increase of TB incidence during adolescence, which may be due to an increase in new infections 6 or following conversion of LTBI to active disease. This makes adolescence suitable for targeted TB disease control interventions that prevent progression of LTBI to active disease. Few studies have documented the prevalence and risk factors of latent TB infection among adolescents [7] [8] [9] . We assessed the prevalence of latent TB infection, and it's risk factors among adolescents in and out of school in two rural district of Eastern Uganda. Knowledge of the epidemiology of latent TB in this age group is important to guide the design of control interventions.
Methods

Study design
We reviewed baseline data for participants enrolled in a prospective cohort study conducted among adolescents to determine the prevalence and incidence of TB disease in the Makerere University School of Public Health Demographic Surveillance Site (DSS) in Eastern Uganda 10 .
Enrolment and baseline assessment for main study
Details of the main study are published elsewhere 11 . The main study enrolled adolescents aged 12-18 years who had resided in the study area for at least three months prior to the study and had no plans of migrating were recruited into the main study cohort. A total of 5000 adolescents were proportionately enrolled from three age strata (12-14, 14-16 and 17-18 years) and followed-up for at least one year.
Enrolled study participants were assessed on two occasions either at their residence or school by study nurses. At the first assessment, a full medical history and focused physical examination was done. Information was collected on socio-demographics, medical history pertaining to signs and symptoms of TB disease, history of household contact with a TB patient within two years prior to enrolment in the study and history of smoking, alcohol consumption and hospitalization within the last six months. Physical examination included inspection of the BCG vaccination site for a scar and TB specific signs. All participants had a tuberculin skin test (TST) performed by sub-dermal administration of two units of tuberculin / purified protein derivative (PPD) from the Staten's Serum Institute, Denmark on the volar aspect of the right forearm using the mantoux technique. Though it was desirable to perform an HIV test on all participants, this was not done due to community concerns. Only participants who had prevalent TB had an HIV test performed.
A second assessment visit was done between 48 and 72 hours after the TST, during which the TST site was examined for an induration. The transverse diameter of the induration at the site was measured using a transparent ruler and recorded in millimeters (mm). All baseline procedures were performed under adequate quality control measures by study nurses who had undergone study tailored training.
Interpretation of TST readings
TST readings were used to determine whether a participant had LTBI or not. A participant was said to have LTBI if they had a positive TST. A TST was considered positive if; the transverse skin induration diameter was greater than or equal to 5 mm in an HIV infected participant, and greater than or equal to 10 mm in a participant without HIV infection.
Eligibility criteria for this study
Baseline data of all participants enrolled in the main study was eligible for inclusion in this study. Data of participants whose skin induration diameter was not measured between 48-72 hours of TST administration were excluded.
Data management
Baseline data of all participants enrolled in the main study was extracted from the Microsoft SQL Server 2008 database into Microsoft Excel 2007 for cleaning. Cross tabulation and calculation of frequencies were done using pivot tables to further edit and clean the data. A data dictionary was also developed to describe values in the variables.
Data analysis
Clean data was then exported to SPSS version 16 for univariate analysis. To describe the characteristics of the study population, we calculated the frequencies of the socio-demographic and predictor variables i.e. age, gender, schooling status, smoking habit, drinking habit, hospitalization history in the six months prior to the study, HIV sero-status, presence of a visible BCG scar and history of household contact with a TB patient in the last two years. We plotted the distribution of TST reading diameters and later categorized the readings as either positive or negative. We calculated the frequency of baseline positive tuberculin skin test to determine the prevalence of LTBI. Data was then exported to STATA version 12 to determine the risk factors of prevalent LTBI. We used a mixed effects binomial model with a logarithmic link function to estimate prevalence ratios (PR) for risk factors of latent tuberculosis infection (LTBI).
Ethical consideration
The study was approved by the Makerere University School of Public Health-Higher Degrees and Research Ethics committee (HDREC), Kampala Uganda and the Uganda National Council of Science and Technology (UNCST). Written informed consent was obtained from the parents or legal guardians of the study participants and the adolescents provided assent.
Results
Enrolment of participants
A total of 4981(99.5%) out of the 5000 adolescents in the main study were included in the analysis for this study. We excluded 19 participants (0.38 %) from the analysis because either they were not available for measurement or the measurement was not done within the study stipulated 48 -72 hours after TST administration.
Characteristics of participants
Overall, 2332 (46.8%) of the study participants were 12-14 years old, 1475 (29.6%) 15 -16 year old and 1174 (23.6%) were 17 -18 years old A total of 4663 (93.6 %) participants were out of school, 235 (4.72%) had a known history of a household TB contact within two years prior to enrolment, 3230 (64.8%) had a visible BCG scar; and six participants (0.12%) were HIV infected. Details of the participant characteristics are summarized in Table 1 .
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∞We excluded 3000 participants with zero TST induration diameters; this graph includes TST readings for 1981 participants.
The distribution of TST induration diameters showed little digit preference, indicating good quality reading; and showed a bimodal distribution with 2 peaks, at 6-8 mm and 12mm (Figure 1 ). 
Prevalence of latent TB infection
The overall prevalence of latent TB infection (LTBI) was 16.1%, (95% confidence interval (CI) 15.1 -17.2).
Risk factors of latent TB infection
At bivariate analysis: a BCG scar, Male gender, age strata 15 -16 years, 17 -18 years, non-school going status, and having no household history of contact with a TB patients had significant association with LTBI among adolescents ( Table 2) .
At multivariable analysis, the binomial regression model was significant (p =0.002 This is could be due to the higher TB incidence rate in South Africa; 857 per 100,000 population compared to Uganda's 175 per 100,000 population 1 . Given that latent TB is a big source of new active disease 4 , a higher incidence of TB disease in South Africa suggests a similarly higher LTBI prevalence than Uganda. Furthermore, the lower LTBI prevalence found in our study may be related to the rural nature of the study population that is associated with a lower risk of TB transmission compared to the more urban setting in which the South Africa study was conducted 8, 10, 11 . Use of two-step TST administration has been found to increase LTBI detection; an increase of 11% TST positivity was found when two-step TST was used in a recent study conducted in two Columbian prisons 12 , but only 2% increase in LTBI in Indian adolescents 13 . A two-step TST administration was not feasible in our community based study and we may thus have underestimated the LTBI prevalence in our study population. Older age was associated with a higher risk of LTBI similar to previous studies involving students 7, 8 . This is due to a larger cumulative exposure to patients with active TB disease with increasing age, as has been observed in high prevalence countries 14, 15 .
Though schools offer a congregate environment ideal for transmission of respiratory infections, we found a higher proportion of adolescents with LTBI among those out of school than those in school. The adolescents out of school are more likely to engage in smoking and alcohol consumption which have been found to increase the risk for TB infection 16, 17 , although we could not confirm that in this study, possibly due to low smoking and alcohol consumption in the study population. The prevalence of LTBI among the male participants was higher than that in the female participants. This is no surprise since the global TB disease burden is higher among males than females 1 . A larger TB disease prevalence among males compared to females was also found in disease surveys conducted in some high prevalence countries like Malawi and Nigeria. This may be attributed to the higher LTBI prevalence in males and/or higher reactivation rate among the males and our study seems to indicate the former.
We found a significant association between previous BCG vaccination and prevalent LTBI in contrast to other studies 8, 18 . This could be due to a false positive LTBI arising from the BCG reaction with the TST, the sole investigation that our study used to determine LTBI. The effect of BCG on TST reactivity has however been shown to wane off after 8-10 years 19, 20 . In Uganda BCG is given at birth, therefore a positive TST among adolescents is more likely to reflect true LTBI. However, TST reactivity to BCG has also been demonstrated long after the period that the effect of the BCG vaccination is expected to have waned off 20 , which may explain why our study found more LTBI among adolescents who had a BCG scar (BCG vaccination). Though the demonstration of TST reactivity to BCG vaccination creates controversy about the use of TST to measure LTBI in countries with high BCG coverage, such as Uganda 21, 22 , studies that used interferon gamma release assays (IGRA's), that are believed not to be affected by BCG have shown no added value in estimation of LTBI in high BCG vaccination areas 7, 8, 22 .
The strength of this study included the use of clinical history coupled with microbiological and radiological investigations to exclude active TB disease among all participants. We were thus able to identify and exclude participants with active TB disease from our analysis to provide a more accurate estimate of LTBI and its risk factors. The study also enrolled both school going and out of school adolescents, the findings of this study therefore give information that can be used to make disease control interventions that are applicable to both categories of adolescents.
Limitations
Our inability to differentiate and subsequently exclude from analysis positive TST reactions due to non-tuberculous mycobacterium (NTM) infection. However the TST distribution diameter had two peaks, with the first peak at an induration diameter ranging between 6-8 mm; this first peak most likely represent NTM. The TST positivity cut-off of 10mm could have largely excluded these reactions due to NTM. In our study the BCG scar was used as a proxy to measure BCG vaccination. However, the use of the scar may not be a reliable proxy, since a part of children who receive BCG vaccination may not develop a scar 23, 24 .
The TST induration we used to determine LTBI is a cell mediated immune reaction which may be compromised by HIV infection 25 . To reduce false negative TST results among HIV infected persons a TST induration cut off diameter of 5mm is recommended 26, 27 . In this study, we failed to obtain consent for HIV testing and so we did not ascertain HIV status of all participants yet we used a TST induration diameter of 10mm as a cut off to determine LTBI on all participants and so we may have underestimated the LTBI prevalence in our study population. However, more than 50% of our study population included adolescents aged 15 -18 years, an age group with a very low HIV prevalence (1.4%), based on the most recent HIV sero-behavioral survey in Uganda 28. More so, we expect an even lower HIV prevalence in those aged 12 -14 years 29 . Thus, HIV infection may not have considerably affected the LTBI prevalence estimates.
Conclusion
Our findings in these rural Eastern Uganda districts of Iganga and Mayuge show that BCG immunization (BCG scar) is significantly associated with TST positivity during adolescence. Latent TB is significantly higher among the non-school going adolescents and those with a household contact, even after correction for age and sex. Routine diagnosis and treatment of Latent TB targeting adolescents out of school may be a crucial intervention for TB disease control in low income countries.
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